September 2, 2021 – OraSure Technologies, Inc. (Bethlehem, PA) announced that CFO Roberto Cuca has resigned from the company to pursue an opportunity within the healthcare industry, effective September 17, 2021.
“I would like to thank Roberto for his service to the Company and wish him well in his future endeavors,” said OraSure President and CEO Stephen Tang, Ph.D. “We remain confident in the outlook for the company as we have seen significant recent demand for our InteliSwab COVID-19 Rapid Test and continuing recovery of our core businesses. As an executive team, we are also focused on our current strategic review process with an eye toward driving long-term growth and shareholder value.”
The company has initiated a search for a permanent CFO with the capabilities and qualifications to support the company’s strategic goals. Both internal and external candidates will be evaluated.
Scott Gleason, current SVP, investor relations and corporate communications, will serve as interim CFO while the company conducts its search process. Prior to joining OraSure, Gleason served as the SVP of investor relations and corporate strategy for Myriad Genetics, Inc., a specialty diagnostic laboratory in the U.S. focused on genetic testing and precision medicine.